Infant 发表于 2025-3-28 17:11:59
http://reply.papertrans.cn/39/3809/380870/380870_41.pngbuoyant 发表于 2025-3-28 21:34:10
Locoregional Therapies for Primary and Secondary Hepatic Malignancies,s, and interventional radiologists. The patients should be selected for a specific targeted therapy after multidisciplinary consensus. Interventional oncology has established its role in the management of hepatic malignancies. Image-guided locoregional therapies decrease the rate of systemic toxicit祸害隐伏 发表于 2025-3-28 23:24:22
Pathologic Features of Primary and Metastatic Hepatic Malignancies,lial cells, fat storing cells and connective tissue cells. Although neoplasms of hepatocytes are the most common, a significant number of both benign and malignant primary liver neoplasms arising from other cell types can develop, such as tumors of bile duct epithelium (Table .). In addition, the li大方不好 发表于 2025-3-29 03:50:44
http://reply.papertrans.cn/39/3809/380870/380870_44.png相同 发表于 2025-3-29 08:52:56
Pathologic Features of Primary Colon, Rectal, and Anal Malignancies,r deaths (Colorectal cancer facts & figures 2014–2016, 2014 [.]). Worldwide, colorectal cancer is the fourth leading cause of death and causes almost 700,000 deaths each year (Cancer: fact sheet No. 297, 2015 [.]). This chapter discusses the clinical and pathologic features of the spectrum of epithe偏离 发表于 2025-3-29 14:23:11
Importance of Adequate Lymphadenectomy in Gastrointestinal Cancer,emains controversial, adequate lymph node examination is required for accurate staging such that patients can receive correct adjuvant treatments and for stratification in clinical trials. Nevertheless, wide variation in the quality of lymph node examination exists in the US and many centers are notdebble 发表于 2025-3-29 16:09:39
Circulating Tumor Cells in Gastrointestinal Cancer: Current Practices and Future Directions,k of adequate biomarkers for screening, diagnosis, staging, and prognosis confounds clinical decision-making and delays potentially effective therapies. Circulating tumor cells (CTCs) are a new biomarker with particular promise in GI cancers, potentially offering clinicians and researchers real-timeAngiogenesis 发表于 2025-3-29 23:44:12
http://reply.papertrans.cn/39/3809/380870/380870_48.pnglocus-ceruleus 发表于 2025-3-30 03:25:27
http://reply.papertrans.cn/39/3809/380870/380870_49.pngresilience 发表于 2025-3-30 06:33:58
http://reply.papertrans.cn/39/3809/380870/380870_50.png